Clinical Trial Update: A Nordic Phase II Study of PTCL Based on Dose-intensive Induction and High-dose Consolidation With ASCT [Phase 2]

View source ↗

Summary

This completed Phase II trial in peripheral T-cell lymphoma evaluated dose-intensive induction followed by high-dose consolidation with autologous stem cell tra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Snippet

Sponsor: University of Aarhus | Conditions: Peripheral T-Cell Lymphoma | Phase 2 | Status: COMPLETED